PD Dr. Stefan Wirtz

Department of Medicine 1 – Gastroenterology, Pneumology and Endocrinology

ILC2 Lung-Homing in Cystic Fibrosis Patients: Functional Involvement of CCR6 and Impact on Respiratory Failure (2020) Schulz-Kuhnt A, Greif V, Hildner K, Knipfer L, Döbrönti M, Zirlik S, Fuchs F, et al. Journal article Group 2 Innate Lymphoid Cells (ILC2) Suppress Beneficial Type 1 Immune Responses During Pulmonary Cryptococcosis (2020) Kindermann M, Knipfer L, Obermeyer S, Müller U, Alber G, Bogdan C, Schleicher U, et al. Journal article The Intratumoral and Intestinal Microbiome in Pancreatic Cancer (2020) Langheinrich M, Wirtz S, Grützmann R, Kersting S, Weber G Conference contribution Altered Diversity and Composition of the Microbiome in Patients with Primary Untreated Colorectal Cancer (2020) Langheinrich M, Wirtz S, Weber K, Grützmann R, Kersting S Conference contribution Participation of the intestinal microbiota in the mechanism of beneficial effect of treatment with synbiotic syngut on experimental colitis under stress conditions (2020) Konturek PC, Konturek K, Brzozowski T, Wojcik D, Magierowski M, Targosz A, Krzysiek-Maczka G, et al. Journal article An in vivo gene delivery approach for the isolation of reasonable numbers of type 2 innate lymphoid cells (2020) Frech M, Knipfer L, Wirtz S, Zaiss M Journal article Interleukin-9 protects from early podocyte injury and progressive glomerulosclerosis in Adriamycin-induced nephropathy (2020) Xiong T, Attar M, Gnirck AC, Wunderlich M, Becker M, Rickassel C, Puelles VG, et al. Journal article A CCL1/CCR8-dependent feed-forward mechanism drives ILC2 functions in type 2-mediated inflammation (2019) Knipfer L, Schulz-Kuhnt A, Kindermann M, Greif V, Symowski C, Vöhringer D, Neurath M, et al. Journal article Modulation of the extrinsic cell death signaling pathway by viral Flip induces acute-death mediated liver failure (2019) Bittel M, Kremer A, Stürzl M, Wirtz S, Stolzer I, Neurath M, Ballon G, Günther C Journal article Targeted deletion of NFAT-Interacting-Protein-(NIP) 45 resolves experimental asthma by inhibiting Innate Lymphoid Cells group 2 (ILC2) (2019) Koch S, Knipfer L, Kölle J, Mirzakhani H, Graser A, Zimmermann T, Kiefer A, et al. Journal article